Table 2.
Spearman's rank correlation between fatigue measures and study variables.
| BASDAI-F | SF-36 VT | |||
|---|---|---|---|---|
| Correlation coefficient | p-value | Correlation coefficient | p-value | |
| Age | −0.069 | 0.269 | 0.162 | 0.037 | 
| Education | −0.158 | 0.028 | 0.116 | 0.174 | 
| Housing | −0.083 | 0.254 | 0.114 | 0.185 | 
| BMI | 0.100 | 0.115 | 0.069 | 0.385 | 
| Duration of disease | 0.031 | 0.617 | 0.005 | 0.948 | 
| BASMI10 | 0.070 | 0.256 | −0.079 | 0.311 | 
| Swollen joint count | 0.108 | 0.081 | −0.135 | 0.083 | 
| Clinically damaged joints | −0.028 | 0.648 | −0.200 | 0.010 | 
| SPARCC enthesitis index | 0.196 | 0.001 | −0.178 | 0.021 | 
| ESR | 0.046 | 0.495 | −0.059 | 0.479 | 
| BASDAI-axial pain | 0.529 | <0.001 | −0.346 | <0.001 | 
| BASDAI-peripheral pain | 0.289 | <0.001 | −0.414 | <0.001 | 
| BASDAI-morning stiffness | 0.347 | <0.001 | −0.376 | <0.001 | 
| BAS-G | 0.468 | <0.001 | −0.424 | <0.001 | 
| BASFI | 0.427 | <0.001 | −0.449 | <0.001 | 
| ASQoL | 0.335 | <0.001 | −0.634 | <0.001 | 
BMI, body mass index; BASMI10, Bath Ankylosing Spondylitis Metrology Index; SPARCC, Spondyloarthritis Research Consortium of Canada; ESR, erythrocyte sedimentation rate; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BAS-G, Bath Ankylosing Spondylitis Global Score; BASFI, Bath Ankylosing Spondylitis Functional Index; ASQoL, Ankylosing Spondylitis Quality of Life.